European Union leaders have failed to settle a fight about the distribution of COVID-19 shots among member states but pledged to strengthen vaccine export controls and production on EU soil amid a shortage of doses and spikes in new cases.
Austrian Chancellor Sebastian Kurz criticised the allocation of shots in the EU, saying that some countries were receiving more than their fair share at the cost of others. As the leader of a coalition of six countries, he demanded a correction mechanism, raising tensions between capitals from where the leaders were holding their remote summit.
When member states have a lot less vaccines available to them than others, then I think this is a big issue for Europe," Kurz said. This could cause damage to the European Union like we haven't seen in a long time.
At the end of the summit, the EU's 27 nations were still locked in a dispute over how an upcoming batch of 10 million doses could be allocated to narrow the vaccine gap between member states and the leaders decided to push the talks to a future meeting of their ambassadors.
Under the joint procurement program set up by the European Commission, doses are allocated on a pro rata basis, but some nations are taking less than their share. A large majority of EU members think the system is working well but said some nations made a mistake to focus on AstraZeneca shots instead of diversifying their vaccine portfolios. AstraZeneca shots are cheaper and easier to handle than vaccines from Pfizer-BioNTech or Moderna but the Anglo-Swedish company has been at loggerheads with the bloc over repeated failures to deliver doses agreed in their contract.
The spread of more contagious virus variants has pushed hospitals in some EU countries to their limit. That, combined with the lack of vaccines available in Europe, has pushed several EU nations to impose strict lockdown measures over the Easter holidays.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)